Business Context and Reporting Period
This Form 8-K is filed by Landec Corporation (not Lifecore Biomedical, Inc., as indicated in the metadata) on August 24, 2020, reporting events occurring between August 20 and August 21, 2020. The filing addresses corporate governance changes, including a new agreement with a significant shareholder and the retirement of a director.
Key Financial Metrics
This filing is a Current Report on Form 8-K and does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The filing text does not provide a clear value for any financial metrics.
Material Changes
- Cooperation Agreement: On August 21, 2020, the Company entered into a Cooperation and Support Agreement with Legion Partners Asset Management, LLC and related investors.
- Board Expansion: The Company agreed to seek stockholder approval to increase the Board of Directors from ten to twelve members at the 2020 Annual Meeting.
- Director Nomination: The Company agreed to nominate Joshua E. Schechter for election to the Board as a Class 2 director, subject to stockholder approval.
- Standstill Provisions: Legion Partners agreed to vote in favor of the Board's nominees and the board expansion, and agreed to a standstill restricting them from acquiring more than 15.0% of the Company's common stock or engaging in proxy solicitations until 30 days prior to the 2021 Annual Meeting nomination deadline.
- Director Departure: Director Fredrick Frank notified the Company on August 20, 2020, that he will not stand for reelection and will retire from the Board effective at the 2020 Annual Meeting. His retirement is not due to a disagreement with the Company.
Guidance, Outlook, and Risks
The filing does not provide financial guidance or operational outlook. Key contingencies and risks include:
- Termination of Agreement: The Cooperation Agreement will terminate if the requisite stockholder approval for the board expansion is not obtained at the 2020 Annual Meeting.
- Change of Control: The Cooperation Agreement will automatically terminate if the Company enters into a definitive agreement for a Change of Control transaction.
Investor Verification Checklist
- Verify the outcome of the vote to increase the Board size from ten to twelve directors at the 2020 Annual Meeting.
- Confirm the election of Joshua E. Schechter to the Board and his appointment to the Nominating and Corporate Governance Committee.
- Monitor Legion Partners' compliance with the 15.0% ownership standstill provision.
- Review the full text of the Cooperation and Support Agreement (Exhibit 10.1) for detailed terms regarding the standstill and voting commitments.